A Pilot immunotherapy Combined w/Stereotactic Ablative Radiotherapy for Pts w/Adv or Met Sarcoma

Cancer
Jeremy Harris
A Pilot Study of Immunotherapy Combined with Stereotactic Ablative Radiotherapy for Patients with Advanced or Metastatic Sarcoma
Soft Tissue

Study Description

The purpose of this research study is to test if a combination of two treatments, immunotherapy and stereotactic ablative radiotherapy (SBRT), can delay tumor growth in patients with cancers that develop in their soft tissues (sarcomas).

Eligibility

You can participate in this study if you satisfy the following criteria:

  • are at least 18 years of age or older
  • have been diagnosed with soft tissue sarcoma
  • are not a candidate for surgery based on your doctor’s assessment

You cannot participate in this study if you satisfy the following criteria:

  • are pregnant or nursing
  • are receiving any other investigational agents
A female nurse attentively holds a tablet, ready to assist with patient care and medical information.

Interested in Participating in this Trial?

Thank you for your interest with our team.

One of our specialists will be in contact with you soon.